Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study.Cobbold, J.F., Atkinson, S., Marchesi, J.R., Smith, A., Wai, S.N., Stove, J., Shojaee‐Moradie, F., Jackson, N., Umpleby, A.M., Fitzpatrick, J. … Holmes, E… and Thomas, E.L., 2018. Hepatology Research, 48(1), pp.69-77.